Limits...
Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women.

Chen Z, Smith M, Du H, Guo Y, Clarke R, Bian Z, Collins R, Chen J, Qian Y, Wang X, Chen X, Tian X, Wang X, Peto R, Li L, China Kadoorie Biobank Collaborative Gro - Int J Epidemiol (2015)

Bottom Line: We examined cross-sectional data on 500 000 adults recruited from 10 diverse localities across China during 2004-08.The main analyses excluded those reported taking any antihypertensive medication, and were adjusted for age, region and education.The overall mean [standard deviation (SD)] BMI was 23.6 (3.3) kg/m(2) and mean WC was 80.0 (9.5) cm.

View Article: PubMed Central - PubMed

Affiliation: Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK, zhengming.chen@ctsu.ox.ac.uk lmlee@vip.163.com.

No MeSH data available.


Related in: MedlinePlus

Association of SBP with BMI by treatment with blood pressure-lowering medication. (a) SBP vs BMI among individuals with or without treatment (conventions as in Figure 1); (b) differences in SBP per 10 kg/m2 of BMI by blood pressure-lowering treatment. Closed squares represent the mean differences in SBP and the horizontal lines represent the corresponding 95% CIs. The dotted vertical line indicates the overall mean difference in SBP among those using medication, and open diamonds indicates this and its 95% CI.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4588860&req=5

dyv012-F7: Association of SBP with BMI by treatment with blood pressure-lowering medication. (a) SBP vs BMI among individuals with or without treatment (conventions as in Figure 1); (b) differences in SBP per 10 kg/m2 of BMI by blood pressure-lowering treatment. Closed squares represent the mean differences in SBP and the horizontal lines represent the corresponding 95% CIs. The dotted vertical line indicates the overall mean difference in SBP among those using medication, and open diamonds indicates this and its 95% CI.

Mentions: To limit effects of any possible measurement error, participants with extreme values of any adiposity measures (e.g. BMI < 15 kg/m2 or ≥40 kg/m2; n = 985) and blood pressures (e.g. SBP < 80 mmHg or ≥250 mmHg; n = 272) or missing data on body fat percentage (n = 241) were excluded. In addition, individuals who reported current use of ACE-inhibitors (n = 7133), beta-blockers (n = 6512), diuretics (n = 1452) or calcium antagonists (n = 14 132) were also excluded, except as shown in Figure 7. After all these exclusions, 486 936 (95%) participants remained for the main analyses.


Blood pressure in relation to general and central adiposity among 500 000 adult Chinese men and women.

Chen Z, Smith M, Du H, Guo Y, Clarke R, Bian Z, Collins R, Chen J, Qian Y, Wang X, Chen X, Tian X, Wang X, Peto R, Li L, China Kadoorie Biobank Collaborative Gro - Int J Epidemiol (2015)

Association of SBP with BMI by treatment with blood pressure-lowering medication. (a) SBP vs BMI among individuals with or without treatment (conventions as in Figure 1); (b) differences in SBP per 10 kg/m2 of BMI by blood pressure-lowering treatment. Closed squares represent the mean differences in SBP and the horizontal lines represent the corresponding 95% CIs. The dotted vertical line indicates the overall mean difference in SBP among those using medication, and open diamonds indicates this and its 95% CI.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4588860&req=5

dyv012-F7: Association of SBP with BMI by treatment with blood pressure-lowering medication. (a) SBP vs BMI among individuals with or without treatment (conventions as in Figure 1); (b) differences in SBP per 10 kg/m2 of BMI by blood pressure-lowering treatment. Closed squares represent the mean differences in SBP and the horizontal lines represent the corresponding 95% CIs. The dotted vertical line indicates the overall mean difference in SBP among those using medication, and open diamonds indicates this and its 95% CI.
Mentions: To limit effects of any possible measurement error, participants with extreme values of any adiposity measures (e.g. BMI < 15 kg/m2 or ≥40 kg/m2; n = 985) and blood pressures (e.g. SBP < 80 mmHg or ≥250 mmHg; n = 272) or missing data on body fat percentage (n = 241) were excluded. In addition, individuals who reported current use of ACE-inhibitors (n = 7133), beta-blockers (n = 6512), diuretics (n = 1452) or calcium antagonists (n = 14 132) were also excluded, except as shown in Figure 7. After all these exclusions, 486 936 (95%) participants remained for the main analyses.

Bottom Line: We examined cross-sectional data on 500 000 adults recruited from 10 diverse localities across China during 2004-08.The main analyses excluded those reported taking any antihypertensive medication, and were adjusted for age, region and education.The overall mean [standard deviation (SD)] BMI was 23.6 (3.3) kg/m(2) and mean WC was 80.0 (9.5) cm.

View Article: PubMed Central - PubMed

Affiliation: Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK, zhengming.chen@ctsu.ox.ac.uk lmlee@vip.163.com.

No MeSH data available.


Related in: MedlinePlus